Dermatoscopy

Three-point checklist CME

Next Previous

Created 2008.

Learning objectives

Introduction

The dermoscopy 3-point checklist for early detection of skin cancer is fairly easy to learn and has a high sensitivity for melanoma. (1) There a high likelihood of malignancy (melanoma or basal cell carcinoma) if a pigmented skin lesion has any two of these criteria. The 3-point checklist has been designed to allow non-experts not to miss detection of melanomas. However, it is not as specific as pattern analysis (described in a later section).

The main aim of the 3-point checklist is to determine whether the lesion being examined should undergo a biopsy. It does not an require accurate diagnosis to be made as the finer features of the lesion are not examined.

Symmetry

The following lesions demonstrate approximate symmetry of colour and structure. Shape is not considered.

The lesions below demonstrate asymmetry of colour or structure in one or two axes. Not all asymmetrical lesions are malignant.

Network

The following lesions are considered to have typical pigment network.

The lesions below have atypical pigment network, with irregular holes and thick lines (broadened network). Streaming or pseudopods would also be considered atypical. Not all lesions with atypical network prove to be malignant.

Blue-white structures

Blue-white structures can refer to any type of blue and/or white colour, i.e. combination of blue-white veil and regression structures, as shown in the following pictures. The colour can be subtle. Not all lesions with blue-white structures are malignant.

Activity

Practice dermoscopy, evaluating skin lesions using the 3-point checklist.

Related information

Next Previous  

Email Newsletter

Would you like to receive our dermatology updates by email?

SIGN UP

Submit your images

We're seeking high-quality photos of skin diseases.  

SUBMIT A PHOTO

Machine Diagnosis

Watch DermNet's proposal to create a 'Skin Disease Image Recognition Tool' - winner of the 2017 'Clinicians' Challenge Active Award' by the NZ Ministry of Health and HiNZ.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter